Inhalerx Ltd
ASX:IRX
Inhalerx Ltd
Research & Development
Inhalerx Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Inhalerx Ltd
ASX:IRX
|
Research & Development
-AU$622.1k
|
CAGR 3-Years
-75%
|
CAGR 5-Years
-141%
|
CAGR 10-Years
N/A
|
|
|
4DMedical Ltd
ASX:4DX
|
Research & Development
-AU$568.2k
|
CAGR 3-Years
54%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pro Medicus Ltd
ASX:PME
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alcidion Group Ltd
ASX:ALC
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Artrya Ltd
ASX:AYA
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Inhalerx Ltd
Glance View
InhaleRx Ltd. engages in the development and commercialization of medical technologies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-01-11. The firm is focused on developing inhaled therapies and medicine delivery systems. The company offers Medihale, an inhaler device with sealed pod designed for use of medical cannabis inhaled formulations. The company utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper proof Medihale Pods provide patients with the additional Medical Cannabis c-liquid security. Its Medihale Starter Kit Pro comes with inhaler battery controller with universal serial bus (USB) charging cable, protective charging case and protective charging case USB charging cable.
See Also
What is Inhalerx Ltd's Research & Development?
Research & Development
-622.1k
AUD
Based on the financial report for Dec 31, 2024, Inhalerx Ltd's Research & Development amounts to -622.1k AUD.
What is Inhalerx Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-141%
Over the last year, the Research & Development growth was 57%. The average annual Research & Development growth rates for Inhalerx Ltd have been -75% over the past three years , -141% over the past five years .
